| BL2 | blocking loop 2 |
| COVID-19 | coronavirus disease 2019 |
| DUB | deubiquitinating enzyme |
| EF | enrichment factor |
| HBA | hydrogen bond acceptor |
| HBD | hydrogen bond donor |
| HCV | hepatitis C virus |
| HIV | human immunodeficiency virus |
| IC50 | half maximal inhibitory concentration |
| ISG | interferon-stimulated gene |
| ISG15 | interferon-stimulated gene 15 |
| LD50 | lethal dose, 50% |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| MLR | multiple linear regression |
| MM–GBSA | molecular mechanics—generalized Born and surface area solvation |
| Mpro | main protease |
| MW | molecular weight |
| PDB | Protein Data Bank |
| PLpro | papain-like protease |
| QSAR | quantitative structure–activity relationship |
| RMSD | root-mean-square deviation |
| SARS-CoV | severe acute respiratory syndrome coronavirus |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| SP | standard precision |
| TEST | Toxicity Estimation Software Tool |
| TPSA | topological polar surface area |
| Ub | ubiquitin |
| Ubl | ubiquitin-like (domain) |
| UbVMe | ubiquitin-vinyl methyl ester |
| UCH-L1 | ubiquitin carboxy-terminal hydrolase L1 |
| UCH-L3 | ubiquitin carboxy-terminal hydrolase L3 |
| WHO | World Health Organization |
| XP | extra precision |